← All terms
CATEGORY: QUALITY SYSTEMS
FDA Form 483
An inspection observation form issued by FDA investigators at the conclusion of a facility inspection. Form 483 lists conditions that may constitute violations of the FD&C Act. Companies must respond within 15 business days.
Last reviewed 2026-08-05 · Reviewed by MedFlux Editorial Board · Editorial policy
WHEN IT APPLIES
FDA Form 483 lists inspectional observations when investigators observe conditions that may violate the FD&C Act and related regulations.
PROCESS / STEPS
- Receive and review observations promptly.
- Investigate root causes; prepare a thorough written response.
- Implement CAPA with effectiveness checks.
- Track to inspection classification outcomes (e.g., VAI/OAI).
EXAMPLES
- Incomplete CAPA responses to 483 observations can escalate to warning letters.
RELATED GUIDES & TOOLS
SOURCES
Track regulatory signals related to FDA Form 483 across 27 authorities in real time.
START FREE →